US Patent Issued to NEW CANCER CURE-BIO on Sept. 8 for "Pharmaceutical composition for preventing or treating cancer comprising 3-ketoacyl CoA thiolase inhibitor and carnitine acylcarnitine carrier inhibitor" (South Korean Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,119, issued on Sept. 8, was assigned to NEW CANCER CURE-BIO Co. LTD. (Goyang-si, South Korea).

"Pharmaceutical composition for preventing or treating cancer comprising 3-ketoacyl CoA thiolase inhibitor and carnitine acylcarnitine carrier inhibitor" was invented by Sooyoul Kim (Goyang-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition tor preventing treating cancer including a 3-ketoacyl CoA thiolase (ACAA) inhibitor and a carat in acylcarnitine carrier (CAC) inhibitor represented by Formula 1 below: where R1 to R4 are each independently H, C1-6 alkyl substituted or unsubstituted with one or more halogen, or C...